Targeted Medical Pharma, Inc. (TRGM)

Targeted Medical Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Revenue	5.26	7.11	9.56	7.3	8.81
Revenue Growth (YoY)	-26.03%	-25.57%	30.96%	-17.18%	15.57%
Cost of Revenue	2.1	2.22	2.99	3.2	2.76
Gross Profit	3.17	4.9	6.57	4.1	6.05
Selling, General & Admin	5.04	7.35	9.77	10.1	11.44
Research & Development	0.01	0.16	0.23	0.13	0.16
Operating Expenses	5.06	7.51	10	10.23	11.6
Operating Income	-1.89	-2.61	-3.43	-6.14	-5.55
Interest Expense	-1.17	-1.23	-0.56	-2.26	-0.88
Interest & Investment Income	-	-	0.57	0.06	0.01
Other Non Operating Income (Expenses)	0.14	0.01	0.16	-	-
EBT Excluding Unusual Items	-2.93	-3.83	-3.26	-8.34	-6.42
Merger & Restructuring Charges	-	-	-	-	-0.23
Other Unusual Items	-0.14	-	-0.41	-4.43	-
Pretax Income	-3.07	-3.83	-3.67	-12.77	-6.65
Income Tax Expense	-	0.07	5.67	-3.19	-2.47
Earnings From Continuing Operations	-3.07	-3.9	-9.34	-9.59	-4.18
Minority Interest in Earnings	0.02	-	-	-	-
Net Income	-3.04	-3.9	-9.34	-9.59	-4.18
Net Income to Common	-3.04	-3.9	-9.34	-9.59	-4.18
Shares Outstanding (Basic)	27	26	24	22	22
Shares Outstanding (Diluted)	27	26	24	22	22
Shares Change (YoY)	3.16%	10.73%	7.56%	0.93%	18.69%
EPS (Basic)	-0.11	-0.15	-0.39	-0.43	-0.19
EPS (Diluted)	-0.11	-0.15	-0.39	-0.43	-0.19
Free Cash Flow	-1.28	0.78	-2.08	-2.49	-2.67
Free Cash Flow Per Share	-0.05	0.03	-0.09	-0.11	-0.12
Gross Margin	60.16%	68.84%	68.72%	56.12%	68.70%
Operating Margin	-35.93%	-36.71%	-35.94%	-84.15%	-63.00%
Profit Margin	-57.86%	-54.76%	-97.72%	-131.38%	-47.41%
Free Cash Flow Margin	-24.30%	10.97%	-21.82%	-34.11%	-30.28%
EBITDA	-1.66	-2.21	-3.02	-5.7	-5.09
EBITDA Margin	-31.55%	-31.06%	-31.63%	-78.18%	-57.80%
D&A For EBITDA	0.23	0.4	0.41	0.44	0.46
EBIT	-1.89	-2.61	-3.43	-6.14	-5.55
EBIT Margin	-35.93%	-36.71%	-35.94%	-84.15%	-63.00%
Revenue as Reported	5.26	7.11	9.56	7.3	8.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.